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INTRODUCTION 
Nanotechnology rest on the synthesis and 
applications of nanoparticles in varied areas such as 
chemistry, physics, biology, and medicine (Pereira 
et al. 2014; Joanna et al. 2018). The use of 
microorganisms for synthesis of nanoparticles have 
emerged as a simple and viable alternative to more 
complex chemical synthetic procedures to obtain 
silver nanoparticles (AgNPs) (Siddiqi et al 2018). 
AgNPs have shown excellent bactericidal 
properties against a wide range of microorganisms 
(Naqvi et al. 2013). Nanoparticles can exhibit size-
related properties significantly different from those 
of either fine particles or bulk materials (Duncan 
2011; Durán et al., 2016). There has been 
worldwide development of multidrug-resistant 
bacteria because of above- or underuse of 
antibiotics (Rai et al. 2017; Khleifat,et al., 2019). 
These bacteria, as well as other types of 
microorganisms, have developed resistance to 
antibiotics, and consequently, this problem is now 
documented as an emergent global challenge (Roca 
et al. 2015). To manage the problem of multidrug 
resistance, new and different antimicrobials are 
required (Allahverdiyev et al. 2011). In this 
context, the use of silver nanoparticles in 
conjunction with different antibiotics and Etoh 
extract (Etoh) may exert antibacterial synergy, 
leading to the emergence of novel approaches for 
therapy. Asteriscus graveolens is an endemic 
Middle Eastern medicinal plant, located in extreme 
desert environments; its major Etoh extract 
components were identified as cis-chrysanthenyl 
acetate, myrtenyl acetate and kessane ( Tayeh et al. 
2018).  
Recent studies reported great antifungal and 
anticancer activities of its ethanol extract of A. 
graveolens. In addition, the ethanol extract of A. 
graveolens showed various degrees of antibacterial 
activity depending on the bacterial strain (Aouissi 
et al. 2018).  
Nanoparticle–antibiotic combinations minimize the 
degree of combined agents in the dosage, which 
lowers noxiousness and raises antimicrobial 
potentials (Naqvi et al. 2013). Furthermore, due to 
this conjugation, the concentrations of antibiotics 
can be increased at the region of antibiotic–microbe 
contact and subsequently facilitate the binding 
between microorganisms and antibiotics 
(Allahverdiyev et al. 2011; Al-Asoufi et al., 2017). 
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Abstract: Antibactrial activity of Asteriscus graveolens methanolic extract and its 
synergy effect with fungal mediated silver nanoparticles (AgNPs) against some enteric 
bacterial human pathogen was conducted. Silver nanoparticles were synthesized by the 
fungal strain namely Tritirachium oryzae W5H as reported early. In this study, MICs of 
AgNPs against E. aerogenes, Salmonella sp., E. coli and C. albicans in order were 2.13, 
19.15, 0.08 and 6.38 µg/mL, respectively, while the MICs of A. graveolens ethanolic 
extract against the same bacteria were 4, 366, <3300 and 40 µg/mL, respectively. The 
MIC values at concentration less than 19.15 and 40 µg/ml indicating the potent 
bacteriostatic effect of AgNPs and A. graveolens ethanolic extract. Increasing in IFA 
was reported when Nitrofurantion and Trimethoprim were combined with Etoh extract 
with maximum increase in IFA by 6 and 12 folds for, respectively. Also, 10 folds 
increasing in IFA was reported when trimethoprim was combined with AgNPs: Etoh 
extract. But, there were no synergistic effect between the antifungal agents (Caspofungin 
and Micafungin) combined with AgNPs and or A. graveolens ethanolic extract against 
C. albicans. The potent synergistic effect of A. graveolens ethanolic extract and/or NPs 
with the conventional antibiotics is novel in inhibiting antibiotics resistant bacteria. In 
this study, remarkable increasing in the antibacterial activity, when the most resistant 
antibiotics combined with A. graveolens ethanolic extract and/or NPs was reported. 
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The aim of the present work is to study the broad-
spectrum antibacterial activity of AgNPs used 
singly and in combination with 6 different 
antibiotics or ethanol extract of A. graveolens 
leaves.  
The effects of the bio-reduced silver nanoparticles 
when synergized with different antibiotics and the 
plant ethanol extract were investigated against three 
bacterial strains using the disc diffusion and 
microdilution methods. The combinations utilized 
in this study were (1), antibiotic plusAgNPs, (2), 
antibiotic plus ethanol extract of A. graveolens 
plants and (3), antibiotic plus AgNPs plus ethanol 
extract of plant. This is the first report using 
Tritirachiumoryzae as source of AgNPs and of the 
antibacterial capacity achieved by combining 
AgNPs and plant ethanol extractwith each tested 
antibiotic. 
 
MATERIALS AND METHODS 
Materials, Growth media, reagents and 
equipment’s 
The fungal strain used in this project was isolated 
from soil samples collected from olive oil mill at 
Al-Karak province, south of Jordan. The fungal 
strain was identified to the species level by ITS 
sequencing (GENWIZ, USA). Sequence similarity 
analysis with NCBI database was performed and 
then the sequence was registered in NCBI database 
and accession number was obtained. 
 
Plant material  
Aerial part of A.graveolens were collected in May 
and June from Dhana Natural Reserve (DNR), 
South of Jordan in 2018. The plants was identified 
as previously reported (Ahmed et al., 1991; 
Sacchetti et al., 2005). 
 
Bacterial strains 
Three bacterial species were used in this study 
including  three Gram-negative bacteria: E. coli 
ATCC 11293, E. aerogenes ATCC 13048 
salmonella ATCC 25664 and one fungal species 
candida albican ATCC 10231 . The clinical 
isolates were obtained from ALkarak Hospital 
(Alkrak- Jordan). E.coli and E.aerogenese were 
obtained from patients with dermatitis 
(opportunistic skin infection) while candida 
albican was isolated from patient with high vaginal 
swab. All isolates were characterized by 
BIOMÉRIEUX VITEK® 2 SYSTEM. In addition, 
the other bacterial strains were all obtained as pure 
cultures from the Department of Biology, Faculty 
of Science, Mutah University, Mutah, Jordan.  
 
Preparation of silver nanoparticls 
For the biosynthesis of AgNPs, the approach 
presented by Jaidev and Narasimha, (2010)was 
taken into account. Furthermore, some changes 
such as the composition of liquid medium were set 
in place, as follows.The identified fungal isolate—
Tritirachium oryzaeW5H was grown aerobically in 
a liquid media with the following chemical 
composition (w/v) 1.0% glucose, 1.0% yeast 
extract and 0.5% NaCl. Hundred-milliliter medium 
was inoculated with fungal spores at a rate of 2.0 × 
106 and incubated at 33 ± 4 ◦C and speed of 150 
rpm in an orbital shaker. After 72 h of incubation, 
the fungal biomass was filtered through Whatmann 
No.1 filter paper followed by extensive washing 
with deionized water. In a glass flask, 10 g (wet 
weight of biomass) was added to 100 ml of 
deionized water and incubated with shaking for 72 
h (35°C at 150 rpm) (Khleifat et al., 2010). Then, 
the fungal biomass in the aqueous suspension was 
filtered through a Whatmann No.1 filter paper and 
the fungal filtrate was lastly obtained. Biosynthesis 
of  AgNPs was attained via adding AgNO3 to 100 
ml of the fungal filtrate to achieve 1 mM 
concentration, which was incubated in the dark at 
35°C and 150 rpm for 96-120 h. Control flask, 
without the AgNO3, was incubated at same 
conditions. Aliquots of the reaction solution were 
taken at 96-120 h of incubation for characterization 
of AgNPs by Ultraviolet-Visible (UV/VIS) 
spectrophotometer analysis. 
 
Ethanolic Extraction of A. graveolens 
The fresh collected materials were air dried at room 
temperature in the shade. Then sample of 50 g of 
the dried plant material were extracted using 500ml 
ethanol and using shaker for 3 days. Then filter 
twice let it dry then we weigh  
 
Preparation of bacterial and fungal suspension 
Bacterial and fungal broth culture were made 
following the Laboratory Standards Institute (CLSI 
M7-A7, 2012). One bacterial and fungal colonies 
were cultivated into sterile 5 ml nutrient broth (NB) 
at 37°C for overnight period incubation. The 
resultant growth culture were adjusted to 0.5 
McFarland Standard using sterile NB broth. The 
adjustment of bacterial and fungal suspensions to 
the density of the 0.5 McFarland standard was done 
spectrophotometrically at (A 620 nm) to obtain a 
final absorbance of 0.1 (Khleifat et al., 2014; 
Khleifat and Abboud, 2003; Khleifat et al., 2006a-
c). 
 
Antimicrobial activity of A.graveolens 
Stock solution of 100 mg/mL Etoh extract  of  A. 
graveolens in DMSO was prepared. For initial 
experiments of well diffusion method, 100 µl from 
the Etoh extract -DMSO solution was loaded to 
each well (10 mg per well). Meanwhile for disc 
diffusion method, 5µl of undiluted Etoh extract was 
applied to each disc (5µg/disc). In MIC assays, 
three-fold dilution series was performed from a 
stock solution of 100 mg/mL to obtain 3300, 1100, 
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370, 123, 40.7, 13.6, 4.53 and 1.5 µg/mL. The 
growth conditions were the same as previously 
mentioned. After 24 h, the zone of inhibition value 
of each sample was documented and compared to 
ethanolic extract alone to verify any synergistic 
effect among the tested antibiotics. 
 
Antimicrobial activity of AgNPs 
Stock solution of 1.726 mg/mL AgNPs was used. 
In well diffusion method, 100µl from the AgNPs 
solution was loaded to each well (172.6 mg per 
well). In the case of disc diffusion method, 5 µl of 
AgNPs solution was applied to each disc (8.63 µg 
per disc). In MIC assay, three-fold dilution series 
was performed from a stock solution (1.726 
mg/mL) to obtain 57.46, 19.15, 6.38, 2.13, 0.71, 
0.24, 0.08 and 0.03 µg/mL.  The effect of AgNPs 
on the growth kinetics was made using growth 
curve and similar concentrations (6.38, 2.13, 0.71, 
0.24, 0.08 and 0.03 µg/mL). 
 
Synergistic effect of AgNPs, Etoh extract 
For synergistic effect using well diffusion assay, a 
50 µl of of each AgNPs and Etoh extract -DMSO 
solutions was combined to obtain a concentration 
of 86.28 µg and 5 mg, respectively. In disc 
diffusion synergistic assay, ready-made antibiotics 
discs were used as follow; amikacin.(30mcg), 
nitrofurantoin (300mcg) gentamicin (10mcg) 
trimethoprim/sulphamethoxazole (1.25/23.75mcg), 
chloramphenicol (30mcg) amoxicillin (20/10 mcg) 
and micafungin (1mg) caspofungin (5mg). To each 
of these antibiotics, in the case of dual synergistic 
effect 10 µl of either AgNPs or Etoh extract  was 
used whereas in case of three-combined substances, 
each tested antibiotic and antifungal disc, 5 µl of 
undiluted Etoh extract (5µg per disc) and/or 5 µl of 
AgNPs solution (8.63µg/disc) were applied 
together (Klančnik et al., 2010). 
 
Determination of minimum inhibitory 
concentration (MIC) 
Minimum inhibition concentration (MIC) values 
were determined using 96-well microtiter plates. 
Three-fold dilution was prepared. Suspensions of 
standard microorganisms adjusted to equivalent to 
0.5 McFarland standards (approximately 
108 CFU/mL for bacteria), were inoculated onto the 
microplates. The growth of the microorganisms 
was monitored by sub cultured of each well content 
on nutrient agar. The MIC values were defined as 
the lowest concentrations of the plant Etoh, NPs, 
Etoh extract+NPs  to inhibit the growth of 
microorganisms (Massa et al., 2018). 
 
RESULTS AND DISCUSSIONS  
Biosynthesis and characterization of AgNPs: 
The fungal strain namely Tritirachium oryzae 
W5H; was previously isolated from this laboratory 
by Al-limoun et al. (2019). The colour of the 
culture filtrate with silver nitrate solution changed 
to intense brown after 72 h. of incubation, whereas, 
the control (silver nitrate salt free solution) did not 
show any colour change (Al-limoun et al., 2019; 
Qaralleh et al., 2019; Khleifat et al., 2019). The 
UV–vis spectrum showed a Surface Plasmon 
Resonance (SPR) peak of silver nanoparticles at 
425 nm (Fig. 1). Morphological characterization of 
AgNP swas conducted using SEM which 
confirmed the presence of silver ions in the solution 
(Fig. 2). Different fungal species have been already 
applied to the synthesis of AgNPs such as 
Aspergillus terreus, Pestalotiopsis sp., Pimelea 
columellifera subsp. Pallida, Aspergillus clavatus, 
Trichoderma harzianum, Penicillium aculeatum, 
Candida albicans, Fusarium verticillioides, and 
Emericella nidulans (Li et al., 2011; Guilger et al., 
2017; Rahimi et al., 2016; Mekkawy et al., 2017). 
This is the first report on the antimicrobial activity 
test on A. graveolens ethanolic extract that was 
synergized with of AgNPs. 
 
 
 
   
Figure1. Ultraviolet-visible spectra of the solution of 1 mM AgNO3 after bioreduction by Tritirachium oryzae W5H at 33°C  
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Figure 2 Representative scanning electron microscopy (SEM) micrograph of Biosynthesized AgNPs by Fungal strain Tritirachium 
oryzae W5H. 
 
Antimicrobial activity of AgNPs, A. graveolens 
ethanolic extract and the synergistic effect 
between Etoh:AgNPs (1:1) using well diffusion 
assay. 
The antimicrobial activity of AgNPs 
andA. graveolens ethanolic extract was evaluated 
using well diffusion method against three gram 
negative strains (E. aerogenes, Salmonella sp. and 
E. coli)and one yeast strain (C. albicans). All 
strains tested except against E. aerogenes showed 
moderate antimicrobial activity toward AgNPs and 
A. graveolens ethanolic extract whereas E. 
aerogenes exhibited a 17 mm zone of inhibition 
(table 1). The antibacterial activity of A. graveolens 
ethanolic extract was higher than the antibacterial 
activity of AgNPs while the candidawas more 
susceptible to AgNPs (13 mm) and higher than that 
of A. graveolens ethanolic extract (7 mm). The 
results also showed that there were no remarkable 
increasing in antimicrobial activity when AgNPs 
was combined with A. graveolens ethanolic extract 
at equal proportion indicating an additive effect 
between them.  
 
The antimicrobial activity was evaluated 
qualitatively using MIC. As shown in table 2, MICs 
of AgNPs against E. aerogenes , Salmonella sp., E. 
coli and C. albicans were 2.13, 19.15, 0.08 and 
6.38 µg/mL, respectively, while the MICs of A. 
graveolens ethanolic extract against the same 
bacteria were 4, 366, <3300 and 40 µg/mL, 
respectively. The MIC values at concentration less 
than 19.15 and 40 µg/ml indicating the potent 
bacteriostatic effect of AgNPs and A. graveolens 
ethanolic extract. The synergistic effect of AgNPs: 
A. graveolens ethanolic extract was also evaluated 
against same pathogens. As shown in table 2, the 
MIC values were decreased when AgNPs was 
tested in combination with the A. graveolens 
ethanolic extract against Salmonella sp and E.coli 
(0.236:4.53 and 0.0789:1.5 µg/mL, respectively). 
C. albicans was more susceptible to AgNPs as 
compared to the tested bacteria. It showed 13 mm 
inhibition zonefollowed by E. aerogenes (12 mm), 
E. coli (11 mm) and Salmonella spwas the most 
resistant one (8 mm). Panáček et al. (2009) showed 
that AgNPs possess antifungal activity against 
Candida sp. at the concentration as low as 
0.21 mg/L. Joanna et al., (2018) reported 
significant antifungal activity of AgNPs against 
Alternaria alternate, Boeremia strassesi, 
Colletotrichum dematium, Colletotrichum fuscum, 
Cylindrocarpon destructans, Diaporthe eres, 
Diplocereus hypericinum, Fusarium equiseti, 
Fusarium oxysporum, Phylloticta plantagnus, 
Rhizoctonia solani, Sclerotinia sclerotiorum, 
Fusarium avenaceum, Fusarium avenaceum. 
Preliminary study performed in our laboratory 
showed that AgNPs possesses broad-spectrum 
antibacterial activity (Tarawneh et al., 2011; 
Khleifat et al., 2019; Qaralleh et al., 2019). 
Guzman et al. (2012) showed that AgNPs 
synthesized chemically exhibited broad-spectrum 
antibacterial activity with maximum activity 
against Escherichia coli, Pseudomonas aeruginosa 
and Staphylococcus aureus. 
 
 
Table 1. Antibacterial activity of A. graveolens ethanolic extract, AgNPs and A. graveolens ethanolic extract:AgNPs (1:1) on the 
tested bacterial strains using well diffusion method. Data are expressed as mean ± SD 
AgNPs+Etoh extract Etoh extract AgNPs Bacterial strain 
18±0.5 17±0.5 12±0 E. aerogenes 
14±0.5 13±0.5 8±0 Salmonella 
10±0 12±0 11±0 E. coli 
11±0 7±20 13±0 C. albicans 
Each well contains 10 µg of A. graveolens ethanolic extract, 172.56 µg AgNPs or 5 µg Etoh: 86.28 µg AgNPs, AgNPs: silver nanoparticles. 
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Table 2. Minimum Inhibitory concentration (MIC) of AgNPs, A. graveolens ethanolic extract and combination of AgNPs: A. 
graveolens ethanolic extract 
NPs+Etoh extract 
(µg/mL) 
Etoh extract 
(µg/mL) 
NPs  (µg/mL) Bacterial strain 
57.52:1100 4 2.13 E. aerogenes 
0.236:4.53 366 19.15 Salmonella 
0.0789:1.5 <3300 0.08 E. coil 
<172.56:<3300 40 6.38 C. albicans 
 
The potential of using AgNPs in antimicrobial 
therapy is due to its multiple mode of bactericidal 
action. These mechanisms involve cell wall, cell 
membrane and key enzymes such as those engaged 
in ATP production, protein synthesis and DNA 
replication (Dorau et al., 2004; Duncan 2011; 
Duran et al., 2016; Tarawneh et al., 2009;  Jung et 
al., 2008; Rauwel et al., 2015; Rahimi et al., 2016; 
Waghmare et al., 2015).  Morones et al. (2005) 
described that the proton motive force of the 
membrane in E. coli dissipates when silver 
nanoparticles favorably bound and localized on the 
membrane of bacterial cells. In addition, the pitting 
of the cell membranes by silver nanoparticles 
causes a rise in permeability and lastly to the death 
of cell (Shahverdi et al., 2007; Lok et al., 2007). In 
particular, AgNPs+ attracted by the surface negative 
charge of the cell, adheres and penetrate the cell 
membrane. The adherent AgNPs inactivate the 
sulfhydryl groups in the cell wall, denature proteins 
and disrupt lipids on the cell membrane. 
Subsequently, this induce autolysis of the cell and 
spell out the cell contents. The intracellular AgNPs 
either bind to DNA and inhibit replication or 
disrupt electron transport chain and inhibit ATP 
production. Moreover, AgNPs have been found to 
facilitate the production of reactive oxygen species 
and induce oxidation damage.  
 
In this study, A. graveolens ethanolic extract 
showed maximum inhibitory activity against E. 
aerogenes (17 mm) followed by Salmonella sp (13 
mm) and E. coli (12 mm) while C. albicans was the 
most resistant strain (7 mm).  Recent report showed 
that the ethyl acetate fraction of A. graveolens has 
moderate antibacterial activity against Listeria 
monocytogenes ATCC 19115 (MIC=0.312 mg/mL) 
(Ramdane et al., 2017).A. graveolens Etoh extract 
rich with 6-oxocyclonerolidol was reported with 
fungicidal activity against Alternaria sp. and P. 
expansum (Znini et al., 2011). 
 
AgNPs synthesized by microorganisms have been 
approved to be good candidates for finding as 
antimicrobial agents. Recent researches showed 
that AgNPs mediated fungi synthesizes possessed 
broad spectrum antimicrobial activity against 
Gram-positive (Bacillus subtilis, Staphylococcus 
aureus, Streptococcus faecalis) and Gram negative 
(Escherichia coli, Klebsiella pneumonia, Proteus 
mirabilis, Pseudomonas fluorescens, Pseudomonas 
aeruginosa, and Salmonella typhi) bacteria 
(Barapatre et al., 2016; Verma et al., 2010; 
Rajendran et al., 2012; Ma et al., 2017). Pereira et 
al., 2014 showed that the AgNPs synthesized from 
P. chrysogenum exhibited stronger antibacterial 
activity comparing to fluconazole. AgNPs 
antimicrobial activity is correlated with several 
aspects including the particle size, shape and 
concentration (Burda et al., 2005; Bhainsa and 
D'Souza, 2006). As the size of the particles 
decrease, the antibacterial activity increased. This 
is due to the smaller size particles diffuse easily 
through the membrane comparing to the larger ones 
(Parthasarathy et al., 2015). It has been found that 
the particles shape (Kitching et al., 2015) also 
influences the antibacterial activity. Complete 
inhibition activity for the triangular AgNPs was at 
1 mg whereas the spherical and rod AgNPs the 
inhibition activities were reported at 12.5 and 50-
100 mg, respectively (Ramalingmam et al., 2015). 
The difference of antimicrobial activity between 
Gram positive and Gram-negative bacteria could be 
due to their variations in structure of cell wall. 
Gram-positive bacteria have a thick peptidoglycan 
layer, while the peptidoglycan layer in the Gram 
negative bacteria is thin but is surrounded by a lipid 
layer (Joanna et al., 2018). 
 
Synergistic effect of AgNPs and/or A. graveolens 
ethanolic extract combined with different 
antibiotics   
Antibiotic-resistant bacteria continue to challenge 
therapeutic practitioners. New model of antibiotics 
are continue expected due to the rise in the 
occurrence of infections caused by multidrug-
resistant (MDR), methicillin-resistant, vancomycin-
resistant, fluoroquinolone-resistant and 
carbapenem-resistant bacteria (Sanglard et al., 
2009). Several strategies have been established to 
overcome the antibiotics resistance problem. One 
of the most common strategy is using active 
components from the natural sources. In addition, 
the use of NPs is considered as one of the most 
promising strategy in drug development. 
Combination therapy that might provide agent with 
multiple target sites are highly advantageous in 
reducing the antibiotics resistance problems. 
 
The synergistic effect of AgNPs and/or A. 
graveolens ethanolic extract combined with 6 
different conventional antibiotics was evaluated 
using disc diffusion method. The synergy effect 
against all tested pathogens was evaluated by an 
increase in fold area (IFA) of individual antibiotics 
and were calculated as C=B2-A2/A2, where, A and 
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B are the inhibition zones (mm) obtained for 
antibiotic alone and antibiotics plus AgNPs or 
antibiotics plus either ethanolic extract or 
combination of three (A +NPs +Ethanolic extract), 
respectively.  In case of no zone of inhibition, 
diameter of the disk (6 mm) was considered for the 
calculation ( Abboud et al., 2009; Padalia et al., 
2015). 
 
As shown in table 3, the most effective antibiotic 
tested against E. coli was Gentamicin (21 mm) 
followed by amikacin (18 mm) in which both were 
not affected by the combination with AgNPs (no 
increase in IFA was reported). Moreover, IFAs of 
Gentamicin and amikacin combined with ethanolic 
extract and or AgNPs were 0.2 indicating weak 
synergistic effect between them. In addition, the 
most resistant strains to the tested antibiotics were 
Nitrofurantion and Amoxicillin. Among these, only 
Nitrofurantion showed synergistic effect when it 
was combined with AgNPs and with AgNPs: 
ethanolic extract since the increase in the IFA was 
by up to1.0 and 0.7 respectively. This enhanced 
antibacterial activity reveals the noticeable 
solicitation in the field of nanomedicine. 
Chloramphenicol and Trimethoprim which 
exhibited moderate antibacterial activity against E. 
coli (13 and 12 mm, respectively)showed no 
synergistic effect except when Chloramphenicol 
was combined with AgNPs (IFA 0.5). 
 
E. aerogenes was resistant to Amoxicillin while it 
was sensitive to amikacin, Gentamicin and 
Trimethoprim. As shown in table 4, no remarkable 
synergistic effect was reported when these 
antibiotics were combined with AgNPs or AgNPs: 
A. graveolens ethanolic extract. The exception of 
these are the increasing in IFA by 1 fold and 0.8 
fold when amikacin was combined with Etoh 
extract and when Nitrofurantion was combined 
with AgNPs: A. graveolens ethanolic extract, 
respectively. IFA, designate an increase in fold area 
of individual antibiotics and were calculated as 
C=B2-A2/A2, where, A and B are the inhibition 
zones (mm) obtained for antibiotic alone and 
antibiotics plus AgNPs or antibiotics plus Etoh of 
plants or combination of three (A +NPs +Etoh), 
respectively.  All experiments were made in 
triplicates except the antibiotics disc was the 
average of twice and standard deviations were 
negligible. In case of no zone of inhibition, 
diameter of the disk (6 mm) was considered for the 
calculation 
 
 
Table 3. Antibacterial activity (inhibition zone mm) of the antibiotics, combination of antibiotics:AgNPs (1:1), antibiotics: A. 
graveolens ethanolic extract (1:1), and antibiotics:AgNPs: A. graveolens ethanolic extract (1:1:1) against E. coli 
IFA A+NPs+Etoh extract IFA Etoh 
extract 
IFA NPs+A A 
Antibiotic(A) 
0.7 8 0 6 1.0 9 6 Nitrofurantion 
- 10 - 10 0.5 16 13 Chloramphenicol 
0.2 20 0.2 20 - 14 18 amikacin 
0.3 14 0.5 15 - 6 12 Trimethoprim 
- 18 - 16 - 10 21 Gentamicin 
- 6 - 6 - 6 6 Amoxicillin 
IFA, designate an increase in fold area of individual antibiotics and were calculated as C=B2-A2/A2, where, A and B are the inhibition zones (mm) obtained for antibiotic alone and 
antibiotics plus AgNPs or antibiotics plus ethanolic extract of plants or combination of three (A +NPs + Etoh extract), respectively.  All experiments were made in triplicates except the 
antibiotics disc was the average of twice and standard deviations were negligible. In case of no zone of inhibition, diameter of the disk (6 mm) was considered for the calculation 
 
Table 4. Antibacterial activity (inhibition zone mm) of the antibiotics, combination of antibiotics:AgNPs (1:1), antibiotics: A. 
graveolens ethanolic extract (1:1), and antibiotics:AgNPs: A. graveolens ethanolic extract (1:1:1) against Enterobacter aerogenes 
IFA A+NPs+Etoh extract IFA Etoh extract IFA NPs+A A Antibiotic(A) 
0.8 22 - 6 - 9 16 Nitrofurantion 
- 6 - 10 - 8 15 Chloramphenicol 
0 20 1.0 30 - 15 20 amikacin 
- 15 - 15 - 6 18 Trimethoprim 
- 16 - 16 - 19 20 Gentamicin 
0 6 0 6 0 6 6 Amoxicillin 
IFA, designate an increase in fold area of individual antibiotics and were calculated as C=B2-A2/A2, where, A and B are the inhibition zones (mm) obtained for antibiotic alone and 
antibiotics plus AgNPs or antibiotics plus Etoh of plants or combination of three (A +NPs +Etoh), respectively.  All experiments were made in triplicates except the antibiotics disc was the 
average of twice and standard deviations were negligible. In case of no zone of inhibition, diameter of the disk (6 mm) was considered for the calculation 
 
Table 5. Antibacterial activity (inhibition zone mm) of the antibiotics, combination of antibiotics:AgNPs (1:1), antibiotics: A. 
graveolens ethanolic extract (1:1), and antibiotics:AgNPs: A. graveolens ethanolic extract (1:1:1) against Salmonella sp. 
IFA A+NPs+Etoh extract IFA Etoh 
extract 
IFA NPs+A A 
Antibiotic(A) 
0 6 6 16 2 11 6 Nitrofurantion 
0.4 22 0.4 22 - 6 18 Chloramphenicol 
- 17 0.2 20 - 13 18 amikacin 
10 20 12 22 - 6 6 Trimethoprim 
0.4 18 0.7 20 - 6 15 Gentamicin 
0.2 20 0.6 23 - 9 18 Amoxicillin 
IFA, designate an increase in fold area of individual antibiotics and were calculated as C=B2-A2/A2, where, A and B are the inhibition zones (mm) obtained for antibiotic alone and 
antibiotics plus AgNPs or antibiotics plus Etoh of plants or combination of three (A +NPs +Etoh), respectively.  All experiments were made in triplicates except the antibiotics disc was the 
average of twice and standard deviations were negligible. In case of no zone of inhibition, diameter of the disk (6 mm) was considered for the calculation 
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Table 6. Antifungal activity (inhibition zone mm) of the antifungals, combination of antifungals:AgNPs (1:1),antifungals:AgNPs: A. 
graveolens ethanolic extract (1:1:1) against C. albicans 
Antifungal conc A + 10 µl AgNps IFA + 5 µAgNps + 5µ Etoh extract IFA 
Caspofungin 14 ng 9 7 - 6 - 
 27 ng 12 14 - 6 - 
       
Micafungin 1 ng 12 6 - 21 0.75 
 5 ng 19 17 - -  
 
Salmonella sp. was resistant to Nitrofurantion and 
Trimethoprim whereas it was sensitive to 
Chloramphenicol, amikacin and Amoxicillin (18 
mm, each). Among the 6 antibiotics tested (table 
5), increases in IFA by 2 fold was reported when 
Nitrofurantion and AgNPswere combined. In 
addition, all antibiotics tested showed IFAs when 
they were combined with Etoh extract achieving 
increase in IFA by 6 and 12 folds for 
Nitrofurantion and Trimethoprim, respectively. In 
addition, 10 folds increase in IFA was obtainedwith 
the combination of Trimethoprim:AgNPs: Etoh 
extract. It was reported that the synthesized silver 
nanoparticles enhanced the antibacterial property of 
carbicillin and moxifloxacin against clinically 
isolated pathogens in combined formulation 
(Althunibat et al., 2016; Gudikandula et al., 2017). 
Similar results were observed in synergistic effect 
of silver nanoparticles with commercial antibiotics 
(ß-lactams, glycopeptides, aminoglycosides and 
sulphonamides) (Thangapandiyan and Prema, 
2012). 
 
Synergistic effect of AgNPs and/or A. graveolens 
ethanolic extract combined with Caspofungin 
and Micafungin against C. albicans 
The synergistic effect of AgNPs with two 
antifungal agents was tested using disc diffusion 
method. Caspofungin and Micafungin were used in 
this study at different concentration. As shown in 
table, Micafungin showed stronger antifungal 
activity than Caspofungin. Maximum inhibition 
zone of 19 mm was reported for Micafungin at 5 ng 
while maximum inhibition zone of 12 mm was 
reported for Caspofungin at 27 ng. On the other 
hand, there were no synergistic effect between 
these two antifungal agents combined with either 
AgNPs  or A. graveolens ethanolic extract. The 
exception of this is the combination of Micafungin 
with 5 µAgNps + 5µ Etoh extract (IFA equal to 
0.75). The use of echinocandins (caspofungin and 
micafungin) is the drug of choice for the treatment 
of invasive candidiasis (Simon et al., 2013; Zeidan 
et al., 2013; Majali et al., 2015). These agents are 
ß-1,3-d-glucan synthase inhibitors. In which this 
enzyme essential for the synthesis of b-1,3-d-
glucan polymers in the cell wall of several fungi 
(Rahimi et al., 2016) reported a potent synergistic 
effect of AgNPs with Caspofungin and Micafungin 
at 4 µg/mL. However, bacterial growth conditions 
can be instrumental in how these microbes respond 
to any antibacterial agents (Khleifat, 2007; Khleifat 
et al., 2007; Abboud et al., 2010; Khleifat et al., 
2015). 
 
CONCLUSION  
The potent synergistic effect of A. graveolens 
ethanolic extract and/or AgNPs with the 
conventional antibiotics seems to be novel in 
inhibiting antibiotics resistant bacteria. Further 
pharmacological assays including in vivo study and 
cytotoxicity should be carried out to confirm the 
novelty of these combinations in treating UTIs. 
Combination therapy has been found to reduce the 
effective dose of antibiotics in the treatment of 
infections. This reduces the side effects and the 
toxicity of the antibiotic (Gibbons et al., 2003; Yap 
et al., 2014). Furthermore, combination therapy 
against resistant bacteria may have different 
mechanism of action and it may lead to find new 
agent that might help in microbial resistance 
management.  
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